The Cancer Care Equity Program (CCEP) aims to place Dana-Farber Cancer Institute at the forefront of efforts to reduce disparities in cancer outcomes to vulnerable patients locally and become a national model for translating disparities research into interventions. To accomplish this, CCEP's work focuses on three initiatives:
The Cancer Care Equity Program is a pilot program for streamlined diagnosis, treatment, and education of underserved patients with suspected malignancy, in collaboration with Whittier Street Health Center, a community health primary care center located in Roxbury, Mass. There are six targeted objectives that the Cancer Care Equity Program (CCEP) hopes to achieve with its Clinical Outreach Initiative:
Dana-Farber Community Cancer Care is a partnership between Whittier Street Health Center and Dana-Farber Cancer Institute. Our comprehensive cancer care program is here to help identify and aid in diagnosis and work-up of suspected oncologic issues. Established patients of Whittier Street Health Center can be seen in our clinic for any of the following reasons:
In 2014 the Cancer Care Equity Program partnered with CVS Pharmacy to begin a lung cancer screening program for patients seen at Dana-Farber Community Cancer Care at Whittier Street Health Center. Through this program, patients are able to have a consultation with one of our oncologists, receive a referral to our smoking cessation counselor for individualized one-on-one smoking cessation counseling, and receive a low-dose CT scan at no cost.
Any patient with a family history of cancer can be seen in our clinic by a Dana-Farber geneticist and genetic counselor. Our genetics team will recommend special screening guidelines for patients with greater risk of developing cancer and help patients through the genetic testing process.
Patients with a new diagnosis of cancer, patients who have been lost to follow-up for a cancer diagnosis, or patients who were diagnosed with cancer in their country of origin will be seen by one of our specialists. We will obtain records from past treatment(s) and will coordinate every aspect of follow-up care.
Patients who are cancer survivors and need to establish a survivorship plan can be referred to one of our oncologists. Based on the treatment the patient received, we will establish a personalized plan of care.
Patients who present with any abnormal or concerning symptoms can be referred to our clinic. We can help arrange further testing of any troublesome symptoms. Patients do not need to have a cancer diagnosis to be seen.
Patients who present with concerning mouth lesions will also be evaluated in our clinic. If needed, we can arrange for an oral biopsy.
Monitoring of adult and pediatric inpatient/outpatient oncology services with consistent documentation of patient sociodemographic data, including clinical trials participation.
Support and facilitation of disparities research and researchers at Dana-Farber, functioning as a conduit between laboratory-based researchers, health services researchers, outreach efforts, community-based researchers, and clinical trialists who focus on disparities research. In collaboration with the Program for Disparities in Risk Reduction, the Initiative to Eliminate Cancer Disparities, and Harvard Catalyst, the Cancer Care Equity Program (CCEP) is responsible for fostering a supportive, cross-disciplinary environment for cancer disparities research. The CCEP's research activities are aligned with the following objectives:
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: